UroMems
PrivateLast Round
Strategic
May 13, 2026
Total Funding Raised
$168.27M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
UroMems is a medical device company that specializes in the design, development, and commercialization of active implantable devices for the treatment of stress urinary incontinence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UroMems Comparables
Compare UroMems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affluent Medical | 90% | |
| Rigicon, Inc. | 84% | |
| Zephyr Surgical Implants | 82% | |
UroMems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 13, 2026 | ||||
| Series C | Jun 25, 2024 | ||||
| Grant | Nov 13, 2023 | ||||
| Series B | Apr 20, 2021 | ||||
| Series B | May 20, 2020 | ||||
Series A | Nov 15, 2016 |
Key People
Founding team and executive leadership
UroMems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series C |
| European Commission (Horizon Europe) | Series C |
| Ajax Health | Strategic |
| Montpensier Arbevel | Series C, Series B |
| Banque Populaire | Series B |
| Supernova Invest | Series B, Series C, Series A |
| Crédit Mutuel Innovation | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 50% MoM.
- Jul 26, 2026
Monthly visitors increased 65% MoM.
UroMems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about UroMems's valuation, stock price, and market status.